• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

    25.37 -0.53 (-2.05%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 19, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Amphastar Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 Next >
    News headline image
    Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024
    Via ACCESSWIRE
    News headline image
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024
    Via ACCESSWIRE
    News headline image
    Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
    Via ACCESS Newswire
    News headline image
    International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
    Via ACCESSWIRE
    News headline image
    Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference
    Via ACCESSWIRE
    News headline image
    Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
    Via ACCESSWIRE
    News headline image
    Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
    Via ACCESSWIRE
    News headline image
    Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024
    Via ACCESSWIRE
    News headline image
    Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts
    These 2 small cap healthcare stocks could boom on a new sector breakout, Wall Street analysts see up to double-digit upside in each 
    Via MarketBeat
    Topics ETFs Economy
    News headline image
    Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
    Via ACCESSWIRE
    News headline image
    Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
    Via ACCESSWIRE
    News headline image
    Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
    Via ACCESSWIRE
    News headline image
    Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
    Via ACCESSWIRE
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.